Stock Appreciation Rights Plan
EXHIBIT 10.5
ZOMEDICA CORP.
2024 STOCK APPRECIATION RIGHTS PLAN
"Affiliate" means a corporation or other entity that, directly or through one or more intermediaries, controls, is controlled by or is under common control with, the Corporation.
"Applicable Laws" means the requirements related to or implicated by the administration of the Plan under applicable state or provincial corporate law, United States federal and state securities laws, the Code, any stock exchange or quotation system on which the shares of Common Stock are listed or quoted, and the applicable laws of any foreign country or jurisdiction where Awards are granted under the Plan.
"Award" means any Stock Appreciation Right granted under the Plan.
"Award Agreement" means a written agreement, contract, certificate or other instrument or document evidencing the terms and conditions of an individual Award granted under the Plan which may, in the discretion of the Corporation, be transmitted electronically to any Participant. Each Award Agreement shall be subject to the terms and conditions of the Plan.
"Board" means the Board of Directors of the Corporation, as constituted at any time.
"Cause" means:
With respect to any Employee or Consultant, unless the applicable Award Agreement states otherwise:
(a) If the Employee or Consultant is a party to an employment or service agreement with the Corporation or its Affiliates and such agreement provides for a definition of Cause, the definition contained therein; or
(b) If no such agreement exists, or if such agreement does not define Cause: “Cause” means that (i) the Participant is convicted of a felony; (ii) the Participant has committed any gross misconduct, theft or fraudulent act, or has acted dishonestly with respect to any business of the Corporation or its Affiliates; (iii) the Participant has materially breached the terms of an employment or consulting agreement between the Participant and the Corporation, any other agreement made between the Participant and the Corporation, or any fiduciary duty the Participant owes to the Corporation; (iv) the Participant has
committed a material violation of Corporation policy that has had or is likely to cause a material adverse effect on the Corporation; or (v) the Participant has failed to perform his/her duties to the Corporation or its Affiliates, which failure has not been cured by the Participant after thirty (30) days advance written notice thereof to the Participant by the Corporation or its Affiliate.
With respect to any Director, unless the applicable Award Agreement states otherwise, a determination by a majority of the disinterested Board members that the Director has engaged in any of the following:
(a) malfeasance in office;
(b) gross misconduct or neglect;
(c) false or fraudulent misrepresentation inducing the director's appointment;
(d) willful conversion of corporate funds; or
(e) repeated failure to participate in Board meetings on a regular basis despite having received proper notice of the meetings in advance.
The Board, in its absolute discretion, shall determine the effect of all matters and questions relating to whether a Participant has been discharged for Cause.
"Change in Control" means and shall be deemed to have occurred upon:
(a)the acceptance by the holders of Shares of the Corporation, representing in the aggregate, more than 50 percent of all issued Shares of the Corporation, of any offer, whether by way of a takeover bid or otherwise, for all or any of the outstanding Shares of the Corporation; or
(b)the acquisition, by whatever means, by a person (or two or more persons who, in such acquisition, have acted jointly or in concert or intend to exercise jointly or in concert any voting rights attaching to the Shares acquired), directly or indirectly, of beneficial ownership of such number of Shares or rights to Shares of the Corporation, which together with such person's then owned Shares and rights to Shares, if any, represent (assuming the full exercise of such rights to voting securities) more than fifty percent (50%) of the combined voting rights of the Corporation's then outstanding Shares; or
(c)the entering into of any agreement by the Corporation to merge, consolidate, amalgamate, initiate an arrangement or be absorbed by or into another corporation; or
(d)the passing of a resolution by the Board or shareholders of the Corporation to substantially liquidate the assets or wind-up the Corporation's business or significantly rearrange its affairs in one or more transactions or series of transactions or the commencement of proceedings for such a liquidation winding-up or re-arrangement (except where such re-arrangement is part of a bona fide reorganization of the Corporation in circumstances where the business of the Corporation is continued and where the shareholdings remain substantially the same following the rearrangement); or
(e)individuals who were members of the Board of the Corporation immediately prior to a meeting of the shareholders of the Corporation involving a contest for or an item of business relating to the election of directors, not constituting a majority of the Board following such election.
"Code" means the Internal Revenue Code of 1986, as it may be amended from time to time. Any reference to a section of the Code shall be deemed to include a reference to any regulations promulgated thereunder.
2
"Committee" means a committee of one or more members of the Board appointed by the Board to administer the Plan in accordance with Section 3.3.
"Common Stock" means the common stock of the Corporation, or such other securities of the Corporation as may be designated by the Board from time to time in substitution thereof.
"Corporation" means Zomedica Corp., a corporation organized under the laws of the Province of Alberta, and any successor thereto.
"Consultant" means any individual or entity that has performed and/or continues to perform services for the Corporation or its Affiliates on an ongoing basis or is expected to provide a service of value to the Corporation or its Affiliates, other than as an Employee or Director.
"Continuous Service" means that the Participant's service with the Corporation or an Affiliate, whether as an Employee, Consultant or Director, is not interrupted or terminated. The Participant's Continuous Service shall not be deemed to have terminated merely because of a change in the capacity in which the Participant renders service to the Corporation or an Affiliate as an Employee, Consultant or Director or a change in the entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant's Continuous Service; provided further that if any Award is subject to Section 409A of the Code, this sentence shall only be given effect to the extent consistent with Section 409A of the Code. For example, a change in status from an Employee of the Corporation to a Director of an Affiliate will not constitute an interruption of Continuous Service. The Board or its delegate, in its sole discretion, may determine whether Continuous Service shall be considered interrupted in the case of any leave of absence approved by that party, including sick leave, military leave or any other personal or family leave of absence. The Board or its delegate, in its sole discretion, may determine whether a transaction, such as a sale or spin-off of a division or subsidiary that employs a Participant, shall be deemed to result in a termination of Continuous Service for purposes of affected Awards, and such decision shall be final, conclusive and binding.
"Director" means a member of the Board or a member of the board of directors of an Affiliate.
"Disability" means, unless the applicable Award Agreement says otherwise, that the Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment. The determination of whether an individual has a Disability shall be determined under procedures established by the Board. The Board may rely on any determination that a Participant is disabled for purposes of benefits under any long-term disability plan maintained by the Corporation or any Affiliate in which a Participant participates, or a determination of total disability made by the Social Security Administration.
"Effective Date" of this Plan shall mean August 12, 2024, the date on which this Plan is adopted by the Board.
"Employee" means any person, including an officer or Director, employed by the Corporation or an Affiliate.
"Exchange Act" means the Securities Exchange Act of 1934, as amended.
"Fair Market Value" means, as of any date, the value of the Common Stock as determined below. If the Common Stock is listed on any established stock exchange or a national market system, including without limitation, the New York Stock Exchange or the Nasdaq Stock Market, the Fair Market Value shall be the closing price of a share of Common Stock (or if no sales were reported the closing price on the date immediately preceding such date) as quoted on such exchange or system on the day of determination, as reported in the Wall Street Journal. In the absence of an established market for the Common Stock, the Fair Market Value shall be determined in good faith by the Board and such determination shall be conclusive and binding on all persons.
3
"Fiscal Year" means the Corporation's fiscal year.
"Grant Date" means the date on which (a) the Board adopts a resolution, or takes other appropriate action, or (b) the President or other Officer takes appropriate action, in either case expressly granting an Award to a Participant that specifies the key terms and conditions of the Award or, if a later date is set forth in such resolution or action, then such date as is set forth in such resolution or action.
"Participant" means an eligible person to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Award.
"Plan" means this Zomedica Corp. 2024 Stock Appreciation Rights Plan, as amended and/or amended and restated from time to time.
"Stock Appreciation Right" means the right pursuant to an Award granted under Section 6 to receive, upon exercise, an amount payable in cash equal to the number of shares subject to the Stock Appreciation Right that is being exercised multiplied by the excess of (a) the Fair Market Value of a share of Common Stock on the date the Award is exercised, over (b) the exercise price specified in the Stock Appreciation Right Award Agreement.
"Substitute Award" has the meaning set forth in Section 4.3.
"Total Share Reserve" has the meaning set forth in Section 4.1.
4
The Board also may modify the exercise price of any outstanding Award, provided that if the modification effects a repricing, shareholder approval shall be required before the repricing is effective.
5
6
7
The Participant (or his beneficiaries) shall be responsible for all taxes with respect to any Stock Appreciation Rights under the Plan, whether arising as a result of the grant or exercise of Stock Appreciation Rights or otherwise. The Corporation makes no representation to the Participant regarding the tax treatment of Stock Appreciation Rights or payments made under the Plan and none of the Corporation, its Affiliates or any of their respective employees or representatives, shall have any liability to the Participant with respect thereto.
8
9
As adopted by the Board of Directors of Zomedica Corp. on August 12, 2024.
10